Literature DB >> 27327410

Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.

Akrivoula Soundia1, Danny Hadaya1, Navid Esfandi1, Rafael Scaf de Molon2, Olga Bezouglaia1, Sarah M Dry3, Flavia Q Pirih4, Tara Aghaloo5, Sotirios Tetradis6.   

Abstract

Osteonecrosis of the jaws (ONJ) is a complication of antiresorptive medications, such as denosumab or bisphosphonates, prescribed to patients with bone malignancy or osteoporosis. The most common instigating local factor in ONJ pathogenesis is tooth extraction. However, in adults the great majority of teeth are extracted due to dental disease. Here, we have investigated alveolar bone healing after extraction of healthy teeth or teeth with naturally occurring periradicular disease in mice treated with high dose zoledronic acid (ZA), a potent bisphosphonate, or OPG-Fc, a RANKL inhibitor. C57BL/6 mice were treated for eight weeks and in vivo micro-CT was performed to identify spontaneously occurring periradicular lesions around the roots of maxillary molars. Then, extractions of molars with and without dental disease were performed in all groups. Four weeks later, animals were euthanized and maxillae were dissected and analyzed. Clinically, all vehicle animals with extraction of healthy or diseased teeth, and most OPG-Fc or ZA animals with extraction of healthy teeth showed normal mucosal healing. On the contrary, most animals with OPG-Fc or ZA treatment and extraction of diseased teeth demonstrated impaired healing with visible mucosal defects. Radiographically, bone socket healing was significantly compromised in OPG-Fc and ZA-treated mice with periradicular disease in comparison to other groups. Histologically, all vehicle animals showed normal mucosal healing and socket remodeling. OPG-Fc and ZA animals with extraction of healthy teeth showed normal mucosal healing, woven bone formation in the socket, and decreased remodeling of the original socket confines. OPG-Fc and ZA animals with extraction of diseased teeth showed mucosal defects, persistent prominent inflammatory infiltrate, bone exposure and areas of osteonecrosis. These findings support that dental disease is critical in the pathogenesis of ONJ, not only as the instigating cause for tooth extraction, but also as a compounding factor in ONJ development and pathophysiology.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dental disease; ONJ; OPG-Fc, extraction; Zoledronic acid

Mesh:

Year:  2016        PMID: 27327410      PMCID: PMC5471352          DOI: 10.1016/j.bone.2016.06.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  45 in total

1.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  C Kilkenny; W J Browne; I C Cuthill; M Emerson; D G Altman
Journal:  Osteoarthritis Cartilage       Date:  2012-04       Impact factor: 6.576

2.  Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.

Authors:  Yasuyoshi Kobayashi; Toru Hiraga; Akimi Ueda; Liyang Wang; Michiyo Matsumoto-Nakano; Kenji Hata; Hirofumi Yatani; Toshiyuki Yoneda
Journal:  J Bone Miner Metab       Date:  2009-10-31       Impact factor: 2.626

3.  RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease.

Authors:  Tara L Aghaloo; Simon Cheong; Olga Bezouglaia; Paul Kostenuik; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

4.  An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats.

Authors:  Pía López-Jornet; Fabio Camacho-Alonso; Francisco Molina-Miñano; Francisco Gómez-García; Vicente Vicente-Ortega
Journal:  J Oral Pathol Med       Date:  2010-08-31       Impact factor: 4.253

5.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

6.  Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.

Authors:  Drake W Williams; Cindy Lee; Terresa Kim; Hideo Yagita; Hongkun Wu; Sil Park; Paul Yang; Honghu Liu; Songtao Shi; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  Am J Pathol       Date:  2014-08-28       Impact factor: 4.307

7.  Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid.

Authors:  M A Dimopoulos; E Kastritis; C Bamia; I Melakopoulos; D Gika; M Roussou; M Migkou; E Eleftherakis-Papaiakovou; D Christoulas; E Terpos; A Bamias
Journal:  Ann Oncol       Date:  2008-08-09       Impact factor: 32.976

8.  Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.

Authors:  Stephen T Sonis; Brynmor A Watkins; Gregory D Lyng; Mark A Lerman; Kenneth C Anderson
Journal:  Oral Oncol       Date:  2008-08-19       Impact factor: 5.337

9.  Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.

Authors:  C I Ripamonti; M Maniezzo; T Campa; E Fagnoni; C Brunelli; G Saibene; C Bareggi; L Ascani; E Cislaghi
Journal:  Ann Oncol       Date:  2008-07-22       Impact factor: 32.976

10.  Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.

Authors:  F Saad; J E Brown; C Van Poznak; T Ibrahim; S M Stemmer; A T Stopeck; I J Diel; S Takahashi; N Shore; D H Henry; C H Barrios; T Facon; F Senecal; K Fizazi; L Zhou; A Daniels; P Carrière; R Dansey
Journal:  Ann Oncol       Date:  2011-10-10       Impact factor: 32.976

View more
  19 in total

1.  Zoledronate Impairs Socket Healing after Extraction of Teeth with Experimental Periodontitis.

Authors:  A Soundia; D Hadaya; N Esfandi; I Gkouveris; R Christensen; S M Dry; O Bezouglaia; F Pirih; N Nikitakis; T Aghaloo; S Tetradis
Journal:  J Dent Res       Date:  2017-09-27       Impact factor: 6.116

Review 2.  Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw.

Authors:  J Chang; A E Hakam; L K McCauley
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

3.  Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ).

Authors:  Ioannis Gkouveris; Danny Hadaya; Akrivoula Soundia; Olga Bezouglaia; Yee Chau; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  Bone       Date:  2019-04-03       Impact factor: 4.398

4.  Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw.

Authors:  Tomoya Soma; Ryotaro Iwasaki; Yuiko Sato; Tami Kobayashi; Satoshi Nakamura; Yosuke Kaneko; Eri Ito; Hiroyuki Okada; Hisato Watanabe; Kana Miyamoto; Morio Matsumoto; Masaya Nakamura; Seiji Asoda; Hiromasa Kawana; Taneaki Nakagawa; Takeshi Miyamoto
Journal:  J Bone Miner Metab       Date:  2020-11-17       Impact factor: 2.626

5.  Medication related osteonecrosis of the jaw in osteoporotic vs oncologic patients-quantifying radiographic appearance and relationship to clinical findings.

Authors:  Kaycee Walton; Tristan R Grogan; Edwin Eshaghzadeh; Danny Hadaya; David A Elashoff; Tara L Aghaloo; Sotirios Tetradis
Journal:  Dentomaxillofac Radiol       Date:  2018-06-28       Impact factor: 2.419

Review 6.  Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.

Authors:  Mampei Kawahara; Shinichiro Kuroshima; Takashi Sawase
Journal:  Int J Implant Dent       Date:  2021-05-14

Review 7.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

8.  Local RANKL delivery improves socket healing in bisphosphonate treated rats.

Authors:  Akrivoula Soundia; Danny Hadaya; Yee Chau; Ioannis Gkouveris; Olga Bezouglaia; Sarah Dry; Flavia Pirih; Tara Aghaloo; Sotirios Tetradis
Journal:  Bone       Date:  2021-04-07       Impact factor: 4.626

9.  Antiresorptive-Type and Discontinuation-Timing Affect ONJ Burden.

Authors:  D Hadaya; A Soundia; I Gkouveris; O Bezouglaia; S M Dry; F Q Pirih; T L Aghaloo; S Tetradis
Journal:  J Dent Res       Date:  2021-01-21       Impact factor: 8.924

10.  The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw.

Authors:  Sotirios Tetradis; Christos Perisanidis; Nikolaos G Nikitakis; Polytimi Paschalidi; Ioannis Gkouveris; Akrivoula Soundia; Evangelos Kalfarentzos; Emmanouil Vardas; Maria Georgaki; Georgios Kostakis; Boban M Erovic
Journal:  Clin Oral Investig       Date:  2020-09-22       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.